BeOne Medicines AG
ONCNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $43.73B
- P/E (TTM)
- 444.96
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $253.95$385.22
- Volume (live)
- -
- Avg. volume (3M)
- 377.85K
BeOne Medicines (ONC) Stock Price & Financial Analysis
BeOne Medicines Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $372.65 - $384.40 |
|---|---|
| 52-Week High | $385.22 |
| 52-Week Low | $253.95 |
| Open | $384.40 |
| Volume (last close) | 315.81K |
| Average Volume (3M) | 377.85K |
| Revenue (TTM) | 918.58M |
|---|---|
| Net Income (TTM) | 98.27M |
| Free Cash Flow (TTM) | 196.26M |
| EPS (TTM) | $0.85 |
| Profit Margin | 10.70% |
| Operating Margin | 15.06% |
| Return on Equity (ROE) | 12.67% |
| Debt to Equity | 0.22 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 43.73B |
|---|---|
| Shares Outstanding | 115.80M |
| P/E Ratio (TTM) | 444.96 |
| Price to Sales (P/S) | 47.60 |
| Price to Book (P/B) | 56.39 |
| EV/EBITDA | 261.25 |
| 50-Day MA | $361.16 |
|---|---|
| 200-Day MA | $323.24 |
| 1-Year Change | +23.30% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
BeOne Medicines at a Glance
As of the Oct 23, 2026 close, BeOne Medicines (ONC) has a market capitalization of $43.73B. The stock trades at 445.0× trailing earnings and 47.6× sales. Over the trailing twelve months it earned $98.27M on revenue of $918.58M (a 10.7% profit margin) and generated $196.26M of free cash flow. Revenue grew 34.4% year over year.
As of its latest reported balance sheet, it holds $764.07M in cash and securities against $171.34M of debt, a net cash position of $592.73M.
BeOne Medicines does not currently pay a dividend.
The share price is up 23.3% over the past year. At $377.63 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $253.95 to $385.22, above its 200-day moving average of $323.24.
Based on 15 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $425.31, 12.6% above the Oct 23, 2026 close.
Frequently Asked Questions About BeOne Medicines
What is the current stock price for ONC?
As of the Oct 23, 2026 close, ONC stock trades at $377.63. The 52-week range is $253.95–$385.22, with a day range of $372.65–$384.40.
What is the P/E ratio for ONC?
As of the Oct 23, 2026 close, BeOne Medicines's trailing twelve-month (TTM) P/E ratio is 445.0, meaning investors pay $445.0 for every $1 of annual earnings. BeOne Medicines operates in the Healthcare sector.
Does ONC pay dividends?
BeOne Medicines does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ONC?
Based on ratings from 15 professional analysts over the last 90 days, the consensus for ONC is Buy. The average 12-month price target is $425.31, a 12.6% upside from the Oct 23, 2026 close of $377.63.
What is the market cap of ONC?
As of the Oct 23, 2026 close, BeOne Medicines's market capitalization is $43.73B, classifying it as a large-cap company. BeOne Medicines operates in the Healthcare sector within the Biotechnology industry.